ALS Invest 1 B.V.
- SEC CIK
- 0001920501
No open-market purchases or sales filed in the past year.
Current role at each company
- AMLX Amylyx Pharmaceuticals, Inc.10% Owneras of Jul 8, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists ALS Invest 1 B.V. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 8, 2022 (view filing) | Jul 6 | 2 days | ALS Invest 1 B.V.10% Owner | SSale | −60.6K | $20.70 | −$1.25M | −1.0%5.90M after | 4 lots |